What Patients Need to Know About Lung Cancer Immunotherapy August 14, 2015December 14, 2022 Michelle Liew
FDA Approves PD-1 Immunotherapy for Most Common Type of Lung Cancer October 2, 2015December 14, 2022 Matthew Tontonoz
FDA Approves Expanded Use of Nivolumab for Lung Cancer October 9, 2015December 14, 2022 Matthew Tontonoz
ASCO 2016 Update: Advances in Immunotherapy for Lung and Blood Cancers June 5, 2016December 14, 2022 Arthur N. Brodsky, PhD
Checkpoint Inhibitors Benefit Lung Cancer Patients in Clinical Trials October 14, 2016December 14, 2022 Arthur N. Brodsky, PhD
FDA Approves Another Immunotherapy Option for Patients with Advanced Lung Cancer October 18, 2016December 14, 2022 Arthur N. Brodsky, PhD